VRTX

VRTX

Vertex Pharmaceuticals Inc
Biotechnology
$434.52 +0.00% As of May 26, 8:50 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

VRTX Volatility Dries Up Near $434.52, Direction TBD

Neutral
May 26, 2026 at 8:50 AM • $434.52 (+0.00%)

Vertex Pharmaceuticals Inc (VRTX) finished unchanged at $434.52 on May 26.

The technical setup looks mixed:

Moving Averages Price sits below both the 9-day ($435.55) and 21-day ($435.96) EMAs, suggesting short-term weakness.
Momentum RSI at 48.3 is in neutral territory. MACD is bullish (-1.09 vs signal -1.53).
Volatility A 20-day TTM Squeeze suggests volatility is coiled and a breakout may be imminent.

Despite the bearish EMA structure, bullish MACD divergence suggests patient buyers may find opportunity near $416.08.

Watch $416.08 as support and $449.98 as resistance.

VRTX Volatility Compresses at $434.52, Breakout Watch

Neutral
May 25, 2026 at 9:00 PM • $434.52 (+0.23%)

Low Volatility Setup: VRTX Squeezes at $434.52

Neutral
May 24, 2026 at 5:55 AM • $434.52 (+0.23%)

Breakout Alert: VRTX Squeeze Intensifies at $434.52

Neutral
May 23, 2026 at 5:45 PM • $434.52 (+0.23%)

TTM Squeeze Tightens Grip on VRTX at $434.52

Neutral
May 22, 2026 at 9:00 PM • $434.52 (+0.23%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $434.52
Daily Change +0.00%
Sentiment Neutral
Sector Biotechnology
Last Updated May 26

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.